Miriam O'Sullivan, Senior Vice President and Chief Human Resources Officer at Boston Scientific Corporation, has reported two significant stock transactions. This update is important as it showcases her active involvement in the company's equity management, which may influence both employee morale and investor confidence in Boston Scientific.

Company Overview

Boston Scientific Corporation, identified by the Central Index Key (CIK) 0000885725, operates in the surgical and medical instruments and apparatus sector. The company is incorporated in Delaware and has its fiscal year ending on December 31. Boston Scientific is headquartered at 300 Boston Scientific Way, Marlborough, MA 01752-1234, and is publicly traded under the symbol BSX.

What the Filing Says

In the recent filing dated November 3, 2026, O'Sullivan reported two transactions involving common stock. On November 1, 2026, she acquired 3,871 shares through a restricted stock unit transaction and disposed of 1,872 shares at a price of $41.98 each. Following these transactions, she owns a total of 21,437 shares directly and an additional 1,731 shares indirectly through her spouse.

Impact

O'Sullivan's actions may affect various stakeholders, including employees and investors. Her engagement with the company's stock could signal confidence in Boston Scientific's future, potentially impacting employee sentiment and investor perspectives regarding the company’s leadership and strategic direction.

What's Next

The filing does not say what happens next.